8/24/2023 0 Comments Tim ny ag ftc necbirnbaumprotocolDaraprim has been the gold standard for treatment of toxoplasmosis for decades - recommended by the Centers for Disease Control and Prevention, the National Institutes of Health, the HIV Medicine Association, and the Infectious Diseases Society of America as the initial therapy of choice for toxoplasmosis. No company or individual has the right to illegally maintain a monopoly and line their pockets at the expense of vulnerable patients.”ĭaraprim is the only Food and Drug Administration (FDA)-approved drug for the treatment of toxoplasmosis, a parasitic disease which may pose serious and often life-threating consequences for those with compromised immune systems, including babies born to women infected with the disease and individuals with the Human Immunodeficiency Virus (HIV). Shkreli’s unlawful conduct will not go unanswered. “A bipartisan group of six additional attorneys general are joining our lawsuit today because Mr. “As the nation battles COVID-19 and individuals with weakened immune systems find themselves more susceptible to the disease, convicted criminal Martin Shkreli and his company still continue to gouge those who are immunocompromised for a life-saving drug,” said Attorney General James. Daraprim is used to treat the parasitic disease toxoplasmosis, and despite Vyera Pharmaceuticals being the only FDA-approved source of the medication, Shkreli and Vyera raised the price of the drug by more than 4,000 percent overnight, to $750 per pill, after they purchased the rights to Daraprim in August 2015. The states of California, Illinois, North Carolina, Ohio, Pennsylvania, and Virginia join the suit originally filed by Attorney General James and the Federal Trade Commission (FTC) against Vyera in January for stifling competition to protect the exorbitant, monopolistic pricing of the drug Daraprim (pyrimethamine). NEW YORK – New York Attorney General Letitia James today announced that the attorneys general of six additional states have joined the lawsuit against Vyera Pharmaceuticals - previously known as Turing Pharmaceuticals - and two of its former CEOs - including convicted criminal Martin Shkreli. Lifetime Ban on Shkreli Working in Pharmaceutical Industry Lawsuit Seeks Repayment of Illegally Obtained Profits, Multiyear Investigation Found Shkreli and Vyera StifledĬompetition After Raising Prices More Than 4,000 Percent
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |